Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
12/2008
12/25/2008US20080318922 Bicyclic Pyrrole Derivatives
12/24/2008WO2009096126A1 Method for producing isoindole and isoindole produced by the method for producing isoindole
12/24/2008WO2008157564A1 Deuterium-enriched eszopiclone
12/24/2008WO2008157162A1 Dipeptide analogs as coagulation factor inhibitors
12/24/2008WO2008156739A1 Heterocyclic compounds and use thereof as erk inhibitors
12/24/2008WO2008156614A2 Imidazopyrazines as protein kinase inhibitors
12/24/2008WO2008155468A1 Activators and therapeutic applications thereof
12/24/2008WO2008155441A1 Activators and therapeutic applications thereof
12/24/2008WO2008155421A2 Indolin-2-ones and aza-indolin-2-ones
12/24/2008WO2008155378A1 Polymorphic and hydrate forms, salts and process for preparing 6-{difluoro[6-(1-methyl-1h-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}quinoline
12/24/2008WO2008155339A2 Labelling methods
12/24/2008WO2008155017A1 Substituted bicyclic heteroaryl compounds for the treatment of cardiovascular diseases
12/24/2008WO2008107543A3 Derivatives of pyrrolopyridine-2-carboxamids, preparation thereof and therapeutic application thereof
12/24/2008WO2008017670A8 Pyrrolo [3, 2 -d] pyrimidines as dpp-iv inhibitors for the treatment of diabetes mellitus
12/24/2008WO2007117653A3 Cdk9-pi3k-akt inhibitors for cancer treatment
12/24/2008WO2006102610A3 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
12/24/2008EP2006290A1 Improved process for producing carbapenem compound
12/24/2008EP2006289A1 Pyrazole-type cyanine dye
12/24/2008EP2004655A1 Polymorphic forms of (2r,z)-2-amino-2-cyclohexyl-n-(5-(1-methyl-1h-pyrazol-4 l)-1-oxo-2,6-dihydro-1h-ý1,2¨diazepinoý4,5,6-cd¨indol-8-yl)acetamide
12/24/2008EP2004654A2 Kinase antagonists
12/24/2008EP2004653A1 3-SUBSTITUTED N-(ARYL- OR HETEROARYL)-PYRAZO[1,5-a]PYRIMIDINES AS KINASE INHIBITORS
12/24/2008EP2004652A1 3-unsubstituted n-(aryl- or heteroarvl)-pyrazolori ý1,5-a¨pyrimidines as kinase inhibitors
12/24/2008EP2004651A2 Novel cyclobutyl compounds as kinase inhibitors
12/24/2008EP2004624A1 Novel bi-aryl amines
12/24/2008EP1633756B1 A2a adenosine receptor antagonists
12/24/2008EP1503996B1 Aryl ketone pyrrolo-triazine compounds useful as kinase inhibitors
12/24/2008EP1390021B1 Delivery of compounds for the treatment of migraine through an inhalation route
12/24/2008CN101331136A Cellulose ester film for optical use, and polarizing plate and liquid crystal display using such cellulose ester film for optical use
12/24/2008CN101331135A Novel imidazopyrazines as cyclin dependent kinase inhibitors
12/24/2008CN101331134A Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof
12/24/2008CN101331133A Sulphonamidoaniline derivatives being Janus kinases inhibitors
12/24/2008CN101330915A Pharmaceutical compositions containing Erythrine mulungu derivatives and processes for their production
12/24/2008CN101328182A Method for producing urotropine and gyphosate solution by using glyphosate waste water
12/24/2008CN101327451A Uses of planar polymerized phthalocyanine or porphyrin transition metal complexes
12/24/2008CN100445286C Preparation method of natural phyllo-iron zinc salt
12/24/2008CN100445285C Nicotinic acetylcholine receptor ligands
12/24/2008CN100445276C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
12/24/2008CA2691417A1 Heterocyclic compounds and use thereof as erk inhibitors
12/24/2008CA2691227A1 Activators and therapeutic applications thereof
12/24/2008CA2690557A1 Imidazopyrazines as protein kinase inhibitors
12/24/2008CA2690545A1 Substituted bicyclic heteroaryl compounds and their use
12/24/2008CA2689663A1 Salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
12/24/2008CA2689158A1 Metabolites of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
12/24/2008CA2687974A1 Labelling methods
12/24/2008CA2687909A1 Indolin-2-ones and aza-indolin-2-ones
12/23/2008US7468459 Process for the preparation of chiral beta amino acid derivatives by asymmetric hydrogenation
12/23/2008US7468372 7-aminosulfonylamino-, aminocarbonylamino- and oxycarbonylamino-substituted pyrrazolo[1,5-a]pyrimidine derivatives, useful in the treatment and prevention of proliferative diseases, for example, cancer, inflammation and arthritis
12/23/2008US7468366 Cytotoxic agents
12/23/2008US7468364 High oral absorption; gramnegative, grampositive bacteria and antibiotic resistant Staphlococcus pneumonia, Hemophilus influenza
12/23/2008US7468179 Aerosol for delivery of naltrexone, buprenorphine, nalbuphine, naloxone, butorphanol, hydromorphone, oxycodone, methadone, remifentanil, sufentanil, or fentanyl by vaporizing the drug, which is coated on support and condensing to form aerosol with mass median aerodynamic diameter of less than 5 microns
12/23/2008US7468080 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof
12/23/2008CA2560580C Imidazole compounds for inhibition of a.beta.-peptide production and for modulation of the notch signaling pathway
12/18/2008WO2008154286A2 Modulation of chemosensory receptors and ligands associated therewith
12/18/2008WO2008154221A2 Modulation of chemosensory receptors and ligands associated therewith
12/18/2008WO2008153947A2 Heterocyclic compounds as raf kinase modulators
12/18/2008WO2008153793A2 Gamma secretase modulators
12/18/2008WO2008153207A1 Bicycloaniline derivative
12/18/2008WO2008152177A1 Intermediates for preparation of an inhibitor of phosphodiesterase type 5
12/18/2008WO2008152013A1 Indolinone derivatives and their use in treating disease-states such as cancer
12/18/2008WO2008151735A2 Heterocyclically substituted heterocyclyl carboxylic acid derivatives
12/18/2008WO2008115974A3 Pyrazolopyrimidine analogs and their use as mtor kinase and pi3 kinase inhibitors
12/18/2008WO2008112695A3 Pyrazolo [3,4-d] pyrimidines and 1, 2, 5, 6-tetraaza- as- indacenes as protein kinase inhibitors for cancer treatment
12/18/2008WO2008094575A3 1-h-pyrazolo(3,4b)pyrimidine derivatives and their use as modulators of mitotic kinases
12/18/2008WO2007136714A3 Integrase inhibitors
12/18/2008WO2007127173A3 Therapeutic compounds
12/18/2008US20080312439 Work-Up in the Preparation of High-Purity Triethylenediamine
12/18/2008US20080312434 Process for imidazo [4,5-c] pyridin-4-amines
12/18/2008US20080312259 SALTS OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE
12/18/2008US20080312258 METABOLITES OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE
12/18/2008US20080312257 Triazolopyrimidine derivatives as ADP P2Y12 receptor antagonists
12/18/2008US20080312228 Pyrimidine compound and medical use thereof
12/18/2008US20080312225 Triazolophthalazines
12/18/2008US20080312211 Antibacterial Pyrrolopyridines, Pyrrolopyrimidines and Pyrroloazepines-154
12/18/2008US20080312078 6-Phenyl-Pyrazolopyrimidine-7-Ylamine Fungicides
12/18/2008US20080312073 made by precipitating a transition metal N4-chelate precursor made of 50:50 molar percent H2 tetraphenyl porphyrin and cobalt tetraphenyl porphyrin onto plurality of removable template particles to produce dispersed precursor and pyrolyzing dispersed precursor to produce a pyropolymer
12/18/2008US20080308006 Diketopyrrolo-Pyrrole Compounds
12/18/2008DE102007027800A1 Substituierte bicyclische Heteroaryl-Verbindungen und ihre Verwendung Substituted bicyclic heteroaryl compounds and their use
12/18/2008CA2690569A1 Indolinone derivatives and their use in treating disease-states such as cancer
12/18/2008CA2689948A1 Gamma secretase modulators
12/17/2008EP2003104A2 Reagent for organic synthesis and method of organic synthesis reaction with the reagent
12/17/2008EP2002837A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
12/17/2008EP2001887A1 Pyrrolo-quinoxalinone derivatives as antibacterials
12/17/2008EP2001886A2 Pyrrolotriazine aniline prodrug compounds useful as kinase inhibitors
12/17/2008EP2001885A2 Octahydro-pyrrolo[3,4-b]pyrrole derivatives
12/17/2008EP2001884A1 Deazapurines useful as inhibitors of janus kinases
12/17/2008EP2001883A2 Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
12/17/2008EP2001882A1 Substituted indazole derivatives, their manufacture and use as pharmaceutical agents
12/17/2008EP1742950B1 Pyrazolo[4,3-d] pyrimidines
12/17/2008EP1716153A4 Methods, compositions, and apparatuses for forming macrocyclic compounds
12/17/2008EP1651685B1 Cucurbituril-containing polymer, stationary phase and column using the same
12/17/2008EP1651623B1 Hexahydrodiazepinones as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
12/17/2008EP1572695B1 Porphyrin derivatives, methods for obtaining same, and use thereof in radioimmunotherapy
12/17/2008EP1443822B1 Substituted thien-3-yl-sulfonylamino(thio)carbonyl-triazolin(thi)ones
12/17/2008EP1306380B1 Novel expanded porphyrins and process for the synthesis thereof
12/17/2008CN101326188A Pyrimidin-4-yl-3,4-dihydro-2h-pyrrolo[1,2A]pyrazin-1-one compounds
12/17/2008CN101326162A Quaternary alpha-aminocarboxamide derivatives as modulators of voltage-gated sodium channels
12/17/2008CN101325954A Quinazolinone derivatives as vanilloid antagonists
12/17/2008CN101323622A 4-biphenylsubstituted pyrazolidin-3,5-dione derivatives
12/17/2008CN101323617A 2,3,4,7-polysubstituted naphthyridine [4,3-d] pyrimidine derivates with sterilization activity and preparation thereof
12/17/2008CN100443555C Fibre-reactive azo dyes, their preparation and their use
1 ... 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 ... 573